"One of the things that I realized the very first time I took a GLP-1 was that all these years I thought that thin people just had more willpower, they ate better foods, they were able to stick to it longer, they never had a potato chip, and then I realized the very first time I took the GLP-1 that, 'Oh, they're not even thinking about it
This can lead to a noticeable improvement in energy, cognitive function, and your general sense of wellness
Clinical trials have shown that over 90% of participants completed their Wegovy treatment programmes despite experiencing symptoms, which means that the challenges you could face are surmountable when you know how and have the right level of support
Abstract Cardiovascular outcome trials of the incretin-based medicines tirzepatide and semaglutide have shown benefits in populations with varying levels of cardiovascular risk
Aitbekov R, Zhumina A, Danilenko MJF
Optimal dosing for neuropathy applications is extrapolated from general tissue repair protocols rather than neuropathy-specific dose-finding studies for most peptides